UnitedHealth Group Incorporated $UNH Shares Sold by Boyd Watterson Asset Management LLC OH

Boyd Watterson Asset Management LLC OH cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 214 shares of the healthcare conglomerate’s stock after selling 53 shares during the quarter. Boyd Watterson Asset Management LLC OH’s holdings in UnitedHealth Group were worth $67,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC increased its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Avidian Wealth Enterprises LLC increased its holdings in shares of UnitedHealth Group by 1.6% in the 1st quarter. Avidian Wealth Enterprises LLC now owns 2,449 shares of the healthcare conglomerate’s stock valued at $1,283,000 after acquiring an additional 39 shares during the last quarter. Amalgamated Bank increased its holdings in shares of UnitedHealth Group by 0.8% in the 1st quarter. Amalgamated Bank now owns 186,742 shares of the healthcare conglomerate’s stock valued at $97,806,000 after acquiring an additional 1,446 shares during the last quarter. Finally, Northwest Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 18.4% in the 1st quarter. Northwest Wealth Management LLC now owns 700 shares of the healthcare conglomerate’s stock valued at $367,000 after acquiring an additional 109 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 1.0%

Shares of UNH stock opened at $365.97 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a fifty day moving average of $339.58 and a two-hundred day moving average of $334.29. The firm has a market capitalization of $331.45 billion, a PE ratio of 15.86, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the firm posted $6.80 EPS. The company’s revenue was up 12.9% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Bank of America boosted their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. KeyCorp boosted their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Finally, Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.